サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1789201

GLP-1アゴニスト市場分析と2034年までの予測：タイプ、製品、技術、用途、エンドユーザー、コンポーネント、デバイス、展開、段階、ソリューション

GLP-1 Agonist Market Analysis and Forecast to 2034: Type, Product, Technology, Application, End User, Component, Device, Deployment, Stage, Solutions

出版日
ページ情報
英文 447 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=149.53円
GLP-1アゴニスト市場分析と2034年までの予測：タイプ、製品、技術、用途、エンドユーザー、コンポーネント、デバイス、展開、段階、ソリューション
出版日: 2025年08月12日
発行: Global Insight Services
ページ情報: 英文 447 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

GLP-1アゴニスト市場は、2024年の530億米ドルから2034年には2,649億米ドルに拡大し、約17.5%のCAGRで成長すると予測されます。GLP-1アゴニスト市場は、グルカゴン様ペプチド-1ホルモンを模倣し、インスリン分泌とグルコース調節を促進する薬剤を中心に構成されています。主に2型糖尿病と肥満管理に使用され、これらの作動薬は代謝療法において極めて重要です。糖尿病罹患率の上昇と肥満率の増加に伴い、同市場は、治療用途の拡大とともに、ドラッグ製剤やデリバリーメカニズムの進歩によって力強い成長を遂げています。

GLP-1アゴニスト市場は、世界の関税と地政学的緊張によって形成された複雑な情勢を乗り越えています。日本や韓国では、企業は現地での研究開発や生産能力への投資を増やすことで、関税の影響を軽減しようと戦略を練っています。輸出規制下にある中国は、サプライチェーンの強靭性を確保するため、国内の医薬品イノベーションへの注力を加速させています。台湾は医薬品製造において極めて重要な役割を担っているが、地政学的な緊張、特に米国と中国が関わる緊張の影響を受けやすいです。親市場は、糖尿病と肥満治療の需要増に牽引され、世界的に力強い成長を遂げています。2035年までには、戦略的提携とサプライチェーンの多様化に基づき、市場は大きく拡大するものと考えられます。中東の紛争は間接的にエネルギー価格に影響を与え、製造コストとスケジュールに影響を与える可能性があります。

市場セグメンテーション
タイプ ペプチド型GLP-1アゴニスト、非ペプチド型GLP-1アゴニスト
製品 注射用GLP-1アゴニスト、経口GLP-1アゴニスト
技術 組換えDNA技術、合成技術、バイオテクノロジー
用途 2型糖尿病、肥満症管理、心血管疾患
エンドユーザー 病院、クリニック、在宅医療現場、研究機関
コンポーネント 原薬、賦形剤、包装材料
デバイス ペン型注射器、プレフィルドシリンジ、自動注射器
展開 入院患者、外来患者
段階 探索、前臨床、臨床検査、商業化
ソリューション 患者アドヒアランスソリューション、デジタルヘルスプラットフォーム

GLP-1アゴニスト市場は、革新的な糖尿病管理ソリューションに対する需要の高まりに後押しされ、堅調な拡大を続けています。医薬品セグメントは、血糖コントロールにおける有効性から注射剤が優位を占めています。経口剤は、利便性と患者の服薬アドヒアランスの向上をもたらし、勢いを増しています。治療用途では、2型糖尿病治療が依然としてトップであり、これはその流行とGLP-1アゴニストの血糖値管理効果に牽引されています。

体重管理は、GLP-1アゴニストによる体重減少と代謝の健康という2つのメリットを反映し、2番目に高いサブセグメントとなっています。同市場では、相乗効果によって治療効果を高める併用療法への関心も高まっています。ドラッグデリバリーシステムの技術的進歩が市場成長をさらに後押しし、患者の使用感や治療成績が向上しています。さらに、研究開発への投資拡大がイノベーションを促進し、有効性と安全性が強化された次世代GLP-1アゴニストへの道を開いています。

GLP-1アゴニスト市場は、既存企業と新興企業が覇権を争う多様な市場シェア動態を特徴とします。価格戦略は、製品のイノベーションと競合のポジショニングに影響され、大きく異なります。最近の製品上市では、新規配合が導入され、治療効果と患者のコンプライアンスが向上しています。市場は、特定の患者のニーズや嗜好に応える個別化医療へのシフトを目の当たりにしています。この進化は、送達メカニズムと患者の転帰の最適化に焦点を当てた研究開発への投資の増加を促進しています。

GLP-1アゴニスト市場の競合は激化しており、主要企業は技術的進歩や戦略的提携を通じて差別化を図っています。特に北米のと欧州のにおける規制の枠組みは、市場の力学を形成する上で極めて重要な役割を果たしています。厳しいガイドラインを遵守することは、市場参入と持続可能性にとって極めて重要です。競合情勢はさらに、特許切れによる影響を受け、ジェネリック医薬品の導入を促進しています。市場分析では、競争優位性を維持するための戦略的提携と技術革新の重要性が強調されています。規制環境は進化を続けており、市場参入企業に課題と機会の両方をもたらしています。

欧州では規制当局の支援と償還施策が市場浸透を促進しています。アジア太平洋では、医療意識の高まりと医療へのアクセスの改善により、市場が急速に拡大しています。中国やインドのような国々は、患者数の多さと医療費の増加を背景に、有利な市場として台頭してきています。ラテンアメリカや中東・アフリカも有望です。これらの地域では医療投資が増加し、慢性疾患管理が重視されるようになっています。ブラジルとサウジアラビアは重要な新興市場として位置づけられており、大きな成長の可能性を秘めています。

一方、イーライリリーは、GLP-1作動薬製品の生産能力を増強するため、製造施設の大幅な拡大を報告しました。この動きは、糖尿病や肥満の管理におけるGLP-1療法の受容と利用の拡大を反映した世界の需要の高まりに対応するものです。

欧州の医薬品庁が新規のGLP-1作動薬にファスト・トラック指定を与えるなど、薬事規制の進展も注目に値するもので、治療パラダイムを変革する可能性が強調されています。これと並行して、Pfizerはアジアの主要製薬企業とジョイントベンチャーを立ち上げ、GLP-1作動薬の流通と入手のしやすさに重点を置いて新興市場への進出を図っています。

さらに、GLP-1の研究開発におけるリソースと専門知識を結集するために、中堅製薬会社2社が手を組むという重要な合併が市場で確認されました。この統合は、業務の合理化と技術革新の促進を目的としており、画期的な治療法の開発につながる可能性があります。

最後に、著名な投資会社がGLP-1アゴニストに特化したバイオテクノロジー企業に多額の資金を提供することを発表し、市場の成長軌道に対する投資家の信頼が強調されました。これらの開発は、GLP-1アゴニスト市場において、各社が戦略的にビジネス機会を生かすためのポジショニングをとっており、ダイナミックかつ急速に進化する状況を示しています。

主要動向と促進要因

GLP-1アゴニスト市場は、世界の糖尿病と肥満の有病率の上昇によって力強い成長を遂げています。この急成長は、GLP-1アゴニストの血糖値管理と減量促進における有効性に対する認知度の高まりによってもたらされています。また、ドラッグデリバリーシステムの進歩により、患者のコンプライアンスと治療成績が向上していることも市場の追い風となっています。

主要動向としては、経口GLP-1アゴニストの開発が挙げられ、注射剤以外の治療選択肢も拡大しています。この技術革新により、患者層が拡大し、市場拡大の原動力となることが期待されます。また、製薬企業間の共同研究や提携により研究開発が加速し、新規製剤の導入につながっています。

さらに、デジタルヘルス技術の統合により、患者のモニタリングとエンゲージメントが強化され、治療へのアドヒアランスが向上しています。遺伝子や表現型のデータに基づいてオーダーメイドの治療を行う個別化医療にもビジネス機会が生まれつつあります。こうしたイノベーションに注力する企業は、大きな市場シェアを獲得する態勢を整えています。効果的な糖尿病管理ソリューションに対する需要の高まりにより、GLP-1アゴニスト市場は継続的な成長が見込まれます。

抑制要因と課題

GLP-1アゴニスト市場は現在、いくつかの重大な市場抑制要因と課題を抱えています。主要課題は、GLP-1アゴニスト療法に関連する高額な費用であり、特に低所得地域の患者にとって利用しやすい環境が制限されています。さらに、GLP-1アゴニストの利点や潜在的な副作用に関する患者や医療従事者の認識や理解が不足しており、GLP-1アゴニストの採用が妨げられています。規制上のハードルや長い承認プロセスが市場拡大をさらに複雑にしており、企業は厳しい要件に直面して製品上市を遅らせています。また、潜在的に低コストで競合する有効性を提供する代替治療の存在も、市場課題となっています。最後に、世界の出来事によって悪化したサプライチェーンの混乱が、これらの医薬品の安定供給に影響を及ぼしており、メーカーと消費者の双方にとって大きな課題となっています。これらの要因は、GLP-1アゴニストの成長と普及にとって手ごわい障壁となっています。

目次

第1章 GLP-1アゴニスト市場概要

  • 調査目的
  • GLP-1アゴニスト市場の定義と調査範囲
  • レポートの制限事項
  • 調査対象年と通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 GLP-1アゴニスト市場展望

  • GLP-1アゴニスト市場セグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 GLP-1アゴニスト市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • 使用事例分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析

第6章 GLP-1アゴニストの市場規模

  • GLP-1アゴニストの市場規模：金額別
  • GLP-1アゴニストの市場規模：数量別

第7章 GLP-1アゴニストの市場規模：タイプ別

  • 市場概要
  • ペプチド型GLP-1アゴニスト
  • 非ペプチド系GLP-1アゴニスト
  • その他

第8章 GLP-1アゴニスト市場：製品別

  • 市場概要
  • 注射用GLP-1作動薬
  • 経口GLP-1作動薬
  • その他

第9章 GLP-1アゴニスト市場：技術別

  • 市場概要
  • 組み換えDNA技術
  • 合成技術
  • バイオテクノロジー
  • その他

第10章 GLP-1アゴニスト市場：用途別

  • 市場概要
  • 2型糖尿病
  • 肥満症
  • 心血管疾患
  • その他

第11章 GLP-1アゴニスト市場：エンドユーザー別

  • 市場概要
  • 病院
  • クリニック
  • 在宅医療
  • 研究機関
  • その他

第12章 GLP-1アゴニスト市場：コンポーネント別

  • 市場概要
  • 原薬
  • 賦形剤
  • 包装材料
  • その他

第13章 GLP-1アゴニスト市場：デバイス別

  • 市場概要
  • ペン型注射器
  • プレフィルドシリンジ
  • 自動注射器
  • その他

第14章 GLP-1アゴニスト市場：展開別

  • 市場概要
  • 入院患者
  • 外来患者
  • その他

第15章 GLP-1アゴニスト市場：段階別

  • 市場概要
  • 探索
  • 前臨床検査
  • 臨床検査
  • 商業化
  • その他

第16章 GLP-1アゴニスト市場：ソリューション別

  • 市場概要
  • 患者アドヒアランスソリューション
  • デジタルヘルスプラットフォーム
  • その他

第17章 GLP-1アゴニスト市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他の欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他のアジア太平洋
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他のラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他の中東・アフリカ

第18章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第19章 企業プロファイル

  • Crane Composites
  • Panolam Industries
  • Lamilux Heinrich Strunz Group
  • Fiber-Tech Industries
  • Enduro Composites
  • Glasteel
  • Nudo Products
  • Polser Fiberglass Reinforced Plastics
  • Strongwell Corporation
  • Brianza Plastica
  • Optiplan GmbH
  • Dongguan Hengsu Green Building Material
  • Fibrosan
  • U.S. Liner Company
  • Resolite FRP Composites
  • Stabilit America
  • Exel Composites
  • Fiberglass Coatings
  • Fiber-Tech Industries
  • Creative Pultrusions
目次
Product Code: GIS33124

GLP-1 Agonist Market is anticipated to expand from $53.0 Billion in 2024 to $264.9 Billion by 2034, growing at a CAGR of approximately 17.5%. The GLP-1 Agonist Market centers on medications that mimic the glucagon-like peptide-1 hormone, enhancing insulin secretion and glucose regulation. Primarily used for type 2 diabetes and obesity management, these agonists are pivotal in metabolic therapy. With rising diabetes prevalence and increasing obesity rates, the market is experiencing robust growth, spurred by advancements in drug formulations and delivery mechanisms, alongside expanding therapeutic applications.

The GLP-1 Agonist Market is navigating a complex landscape shaped by global tariffs and geopolitical tensions. In Japan and South Korea, companies are strategizing to mitigate the impact of tariffs by increasing investments in local R&D and production capabilities. China, under export restrictions, is accelerating its focus on domestic pharmaceutical innovation to ensure supply chain resilience. Taiwan, while maintaining its pivotal role in pharmaceutical manufacturing, is vulnerable to geopolitical tensions, particularly those involving the US and China. The parent market is witnessing robust growth globally, driven by rising demand for diabetes and obesity treatments. By 2035, the market is poised for significant expansion, contingent on strategic alliances and diversified supply chains. Middle East conflicts may indirectly influence energy prices, affecting manufacturing costs and timelines.

Market Segmentation
TypePeptide-based GLP-1 Agonists, Non-peptide GLP-1 Agonists
ProductInjectable GLP-1 Agonists, Oral GLP-1 Agonists
TechnologyRecombinant DNA Technology, Synthetic Technology, Biotechnology
ApplicationType 2 Diabetes, Obesity Management, Cardiovascular Disease
End UserHospitals, Clinics, Homecare Settings, Research Institutes
ComponentActive Pharmaceutical Ingredients, Excipients, Packaging Materials
DevicePen Injectors, Prefilled Syringes, Autoinjectors
DeploymentIn-patient Settings, Out-patient Settings
StageDiscovery, Preclinical, Clinical Trials, Commercialization
SolutionsPatient Adherence Solutions, Digital Health Platforms

The GLP-1 Agonist Market is experiencing robust expansion, propelled by rising demand for innovative diabetes management solutions. The pharmaceutical segment dominates, with injectable formulations leading due to their efficacy in glycemic control. Oral formulations are gaining momentum, offering convenience and improved patient adherence. Within therapeutic applications, type 2 diabetes treatment remains the top-performing sub-segment, driven by its prevalence and the efficacy of GLP-1 agonists in managing blood glucose levels.

Weight management emerges as the second-highest performing sub-segment, reflecting the dual benefits of GLP-1 agonists in weight reduction and metabolic health. The market is also witnessing increased interest in combination therapies, enhancing treatment outcomes through synergistic effects. Technological advancements in drug delivery systems are further propelling market growth, improving patient experience and therapeutic outcomes. Additionally, growing investments in research and development are fostering innovation, paving the way for next-generation GLP-1 agonists with enhanced efficacy and safety profiles.

GLP-1 Agonist Market is characterized by diverse market share dynamics, with established players and emerging companies vying for dominance. Pricing strategies vary significantly, influenced by product innovation and competitive positioning. Recent product launches have introduced novel formulations, enhancing therapeutic efficacy and patient compliance. The market is witnessing a shift towards personalized medicine, catering to specific patient needs and preferences. This evolution is fostering increased investment in research and development, with a focus on optimizing delivery mechanisms and patient outcomes.

Competition in the GLP-1 Agonist Market is intensifying, with key players differentiating through technological advancements and strategic partnerships. Regulatory frameworks, particularly in North America and Europe, play a pivotal role in shaping market dynamics. Compliance with stringent guidelines is crucial for market entry and sustainability. The competitive landscape is further influenced by patent expirations, driving generic drug introductions. Market analysis underscores the importance of strategic alliances and innovation in maintaining competitive advantage. The regulatory environment continues to evolve, presenting both challenges and opportunities for market participants.

Geographical Overview:

The GLP-1 agonist market is witnessing robust growth across various regions, each presenting unique opportunities. North America remains at the forefront, driven by rising obesity rates and a strong focus on diabetes management. The region's healthcare infrastructure and ongoing research initiatives further bolster market expansion. Europe follows closely, with an increasing prevalence of lifestyle-related diseases and a growing elderly population.

Regulatory support and reimbursement policies in Europe enhance market penetration. In the Asia Pacific, the market is expanding rapidly due to rising healthcare awareness and improving access to medical care. Countries like China and India are emerging as lucrative markets, driven by large patient populations and increasing healthcare expenditure. Latin America and the Middle East & Africa are also showing promise. These regions are experiencing an uptick in healthcare investments and a growing emphasis on chronic disease management. Brazil and Saudi Arabia are poised as key emerging markets, offering substantial growth potential.

Recent Developments:

In recent months, the GLP-1 agonist market has experienced pivotal developments, underscoring its burgeoning potential. Novo Nordisk announced a strategic collaboration with a biotech startup to enhance its GLP-1 pipeline, aiming to accelerate the development of next-generation therapies. This partnership is expected to bolster Novo Nordisk's position in the market, leveraging innovative technologies to address unmet medical needs.

Meanwhile, Eli Lilly reported a significant expansion of its manufacturing facilities, specifically to increase the production capacity of its GLP-1 agonist products. This move comes in response to rising global demand, reflecting the growing acceptance and utilization of GLP-1 therapies in managing diabetes and obesity.

Regulatory advancements have also been noteworthy, with the European Medicines Agency granting a fast-track designation to a novel GLP-1 agonist, highlighting its potential to transform treatment paradigms. In parallel, Pfizer has entered a joint venture with a leading Asian pharmaceutical company to penetrate emerging markets, focusing on the distribution and accessibility of GLP-1 agonists.

Moreover, the market witnessed a significant merger, with two mid-sized pharmaceutical companies joining forces to pool resources and expertise in GLP-1 research and development. This consolidation aims to streamline operations and foster innovation, potentially leading to groundbreaking therapies.

Lastly, a prominent investment firm announced a substantial financial commitment to a biotech company specializing in GLP-1 agonists, underscoring investor confidence in the market's growth trajectory. These developments collectively signify a dynamic and rapidly evolving landscape, with companies strategically positioning themselves to capitalize on the opportunities within the GLP-1 agonist market.

Key Trends and Drivers:

The GLP-1 Agonist Market is experiencing robust growth, spurred by rising prevalence of diabetes and obesity globally. This surge is driven by increasing awareness of GLP-1 agonists\u2019 efficacy in managing blood glucose levels and promoting weight loss. The market is also benefiting from advancements in drug delivery systems, enhancing patient compliance and treatment outcomes.

Key trends include the development of oral GLP-1 agonists, expanding treatment options beyond injectable forms. This innovation is expected to broaden the patient base and drive market expansion. Additionally, collaborations and partnerships among pharmaceutical companies are accelerating research and development efforts, leading to the introduction of novel formulations.

Furthermore, the integration of digital health technologies is enhancing patient monitoring and engagement, improving adherence to therapy. Opportunities are emerging in personalized medicine, where tailored treatments based on genetic and phenotypic data are gaining traction. Companies focusing on these innovations are poised to capture significant market share. With the rising demand for effective diabetes management solutions, the GLP-1 Agonist Market is set for continued growth.

Restraints and Challenges:

The GLP-1 Agonist Market is currently navigating several significant restraints and challenges. A predominant issue is the high cost associated with GLP-1 agonist therapies, which limits accessibility for patients, particularly in low-income regions. Additionally, there exists a substantial lack of awareness and understanding among both patients and healthcare providers regarding the benefits and potential side effects of GLP-1 agonists, hindering their adoption. Regulatory hurdles and lengthy approval processes further complicate market expansion, as companies face stringent requirements that delay product launches. The market is also challenged by the presence of alternative treatments and therapies, which offer competitive efficacy at potentially lower costs. Lastly, supply chain disruptions, exacerbated by global events, have impacted the consistent availability of these medications, posing a significant challenge for both manufacturers and consumers. These factors collectively pose formidable barriers to the growth and widespread adoption of GLP-1 agonists.

Key Companies:

Novo Nordisk, Eli Lilly and Company, AstraZeneca, Sanofi, Boehringer Ingelheim, Intarcia Therapeutics, Hanmi Pharmaceutical, Zydus Cadila, Oramed Pharmaceuticals, Adocia, Chugai Pharmaceutical, Dong-A ST, Emisphere Technologies, Amgen, Pfizer, Luye Pharma Group, GSK, Takeda Pharmaceutical Company, MannKind Corporation, Biocon

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: GLP-1 Agonist Market Overview

  • 1.1 Objectives of the Study
  • 1.2 GLP-1 Agonist Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Technology
  • 2.6 Key Highlights of the Market, by Application
  • 2.7 Key Highlights of the Market, by End User
  • 2.8 Key Highlights of the Market, by Component
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Deployment
  • 2.11 Key Highlights of the Market, by Stage
  • 2.12 Key Highlights of the Market, by Solutions
  • 2.13 Key Highlights of the Market, by North America
  • 2.14 Key Highlights of the Market, by Europe
  • 2.15 Key Highlights of the Market, by Asia-Pacific
  • 2.16 Key Highlights of the Market, by Latin America
  • 2.17 Key Highlights of the Market, by Middle East
  • 2.18 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Technology
  • 3.5 Market Attractiveness Analysis, by Application
  • 3.6 Market Attractiveness Analysis, by End User
  • 3.7 Market Attractiveness Analysis, by Component
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Deployment
  • 3.10 Market Attractiveness Analysis, by Stage
  • 3.11 Market Attractiveness Analysis, by Solutions
  • 3.12 Market Attractiveness Analysis, by North America
  • 3.13 Market Attractiveness Analysis, by Europe
  • 3.14 Market Attractiveness Analysis, by Asia-Pacific
  • 3.15 Market Attractiveness Analysis, by Latin America
  • 3.16 Market Attractiveness Analysis, by Middle East
  • 3.17 Market Attractiveness Analysis, by Africa

4: GLP-1 Agonist Market Outlook

  • 4.1 GLP-1 Agonist Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: GLP-1 Agonist Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: GLP-1 Agonist Market Size

  • 6.1 GLP-1 Agonist Market Size, by Value
  • 6.2 GLP-1 Agonist Market Size, by Volume

7: GLP-1 Agonist Market , by Type

  • 7.1 Market Overview
  • 7.2 Peptide-based GLP-1 Agonists
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Non-peptide GLP-1 Agonists
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Others
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region

8: GLP-1 Agonist Market , by Product

  • 8.1 Market Overview
  • 8.2 Injectable GLP-1 Agonists
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Oral GLP-1 Agonists
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Others
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region

9: GLP-1 Agonist Market , by Technology

  • 9.1 Market Overview
  • 9.2 Recombinant DNA Technology
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Synthetic Technology
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Biotechnology
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: GLP-1 Agonist Market , by Application

  • 10.1 Market Overview
  • 10.2 Type 2 Diabetes
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Obesity Management
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Cardiovascular Disease
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: GLP-1 Agonist Market , by End User

  • 11.1 Market Overview
  • 11.2 Hospitals
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Clinics
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Homecare Settings
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Research Institutes
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Others
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region

12: GLP-1 Agonist Market , by Component

  • 12.1 Market Overview
  • 12.2 Active Pharmaceutical Ingredients
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Excipients
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Packaging Materials
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: GLP-1 Agonist Market , by Device

  • 13.1 Market Overview
  • 13.2 Pen Injectors
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Prefilled Syringes
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Autoinjectors
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: GLP-1 Agonist Market , by Deployment

  • 14.1 Market Overview
  • 14.2 In-patient Settings
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Out-patient Settings
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: GLP-1 Agonist Market , by Stage

  • 15.1 Market Overview
  • 15.2 Discovery
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Preclinical
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Clinical Trials
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Commercialization
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region
  • 15.6 Others
    • 15.6.1 Key Market Trends & Opportunity Analysis
    • 15.6.2 Market Size and Forecast, by Region

16: GLP-1 Agonist Market , by Solutions

  • 16.1 Market Overview
  • 16.2 Patient Adherence Solutions
    • 16.2.1 Key Market Trends & Opportunity Analysis
    • 16.2.2 Market Size and Forecast, by Region
  • 16.3 Digital Health Platforms
    • 16.3.1 Key Market Trends & Opportunity Analysis
    • 16.3.2 Market Size and Forecast, by Region
  • 16.4 Others
    • 16.4.1 Key Market Trends & Opportunity Analysis
    • 16.4.2 Market Size and Forecast, by Region

17: GLP-1 Agonist Market , by Region

  • 17.1 Overview
  • 17.2 North America
    • 17.2.1 Key Market Trends and Opportunities
    • 17.2.2 North America Market Size and Forecast, by Type
    • 17.2.3 North America Market Size and Forecast, by Product
    • 17.2.4 North America Market Size and Forecast, by Technology
    • 17.2.5 North America Market Size and Forecast, by Application
    • 17.2.6 North America Market Size and Forecast, by End User
    • 17.2.7 North America Market Size and Forecast, by Component
    • 17.2.8 North America Market Size and Forecast, by Device
    • 17.2.9 North America Market Size and Forecast, by Deployment
    • 17.2.10 North America Market Size and Forecast, by Stage
    • 17.2.11 North America Market Size and Forecast, by Solutions
    • 17.2.12 North America Market Size and Forecast, by Country
    • 17.2.13 United States
      • 17.2.9.1 United States Market Size and Forecast, by Type
      • 17.2.9.2 United States Market Size and Forecast, by Product
      • 17.2.9.3 United States Market Size and Forecast, by Technology
      • 17.2.9.4 United States Market Size and Forecast, by Application
      • 17.2.9.5 United States Market Size and Forecast, by End User
      • 17.2.9.6 United States Market Size and Forecast, by Component
      • 17.2.9.7 United States Market Size and Forecast, by Device
      • 17.2.9.8 United States Market Size and Forecast, by Deployment
      • 17.2.9.9 United States Market Size and Forecast, by Stage
      • 17.2.9.10 United States Market Size and Forecast, by Solutions
      • 17.2.9.11 Local Competition Analysis
      • 17.2.9.12 Local Market Analysis
    • 17.2.1 Canada
      • 17.2.10.1 Canada Market Size and Forecast, by Type
      • 17.2.10.2 Canada Market Size and Forecast, by Product
      • 17.2.10.3 Canada Market Size and Forecast, by Technology
      • 17.2.10.4 Canada Market Size and Forecast, by Application
      • 17.2.10.5 Canada Market Size and Forecast, by End User
      • 17.2.10.6 Canada Market Size and Forecast, by Component
      • 17.2.10.7 Canada Market Size and Forecast, by Device
      • 17.2.10.8 Canada Market Size and Forecast, by Deployment
      • 17.2.10.9 Canada Market Size and Forecast, by Stage
      • 17.2.10.10 Canada Market Size and Forecast, by Solutions
      • 17.2.10.11 Local Competition Analysis
      • 17.2.10.12 Local Market Analysis
  • 17.1 Europe
    • 17.3.1 Key Market Trends and Opportunities
    • 17.3.2 Europe Market Size and Forecast, by Type
    • 17.3.3 Europe Market Size and Forecast, by Product
    • 17.3.4 Europe Market Size and Forecast, by Technology
    • 17.3.5 Europe Market Size and Forecast, by Application
    • 17.3.6 Europe Market Size and Forecast, by End User
    • 17.3.7 Europe Market Size and Forecast, by Component
    • 17.3.8 Europe Market Size and Forecast, by Device
    • 17.3.9 Europe Market Size and Forecast, by Deployment
    • 17.3.10 Europe Market Size and Forecast, by Stage
    • 17.3.11 Europe Market Size and Forecast, by Solutions
    • 17.3.12 Europe Market Size and Forecast, by Country
    • 17.3.13 United Kingdom
      • 17.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 17.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 17.3.9.3 United Kingdom Market Size and Forecast, by Technology
      • 17.3.9.4 United Kingdom Market Size and Forecast, by Application
      • 17.3.9.5 United Kingdom Market Size and Forecast, by End User
      • 17.3.9.6 United Kingdom Market Size and Forecast, by Component
      • 17.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 17.3.9.8 United Kingdom Market Size and Forecast, by Deployment
      • 17.3.9.9 United Kingdom Market Size and Forecast, by Stage
      • 17.3.9.10 United Kingdom Market Size and Forecast, by Solutions
      • 17.3.9.11 Local Competition Analysis
      • 17.3.9.12 Local Market Analysis
    • 17.3.1 Germany
      • 17.3.10.1 Germany Market Size and Forecast, by Type
      • 17.3.10.2 Germany Market Size and Forecast, by Product
      • 17.3.10.3 Germany Market Size and Forecast, by Technology
      • 17.3.10.4 Germany Market Size and Forecast, by Application
      • 17.3.10.5 Germany Market Size and Forecast, by End User
      • 17.3.10.6 Germany Market Size and Forecast, by Component
      • 17.3.10.7 Germany Market Size and Forecast, by Device
      • 17.3.10.8 Germany Market Size and Forecast, by Deployment
      • 17.3.10.9 Germany Market Size and Forecast, by Stage
      • 17.3.10.10 Germany Market Size and Forecast, by Solutions
      • 17.3.10.11 Local Competition Analysis
      • 17.3.10.12 Local Market Analysis
    • 17.3.1 France
      • 17.3.11.1 France Market Size and Forecast, by Type
      • 17.3.11.2 France Market Size and Forecast, by Product
      • 17.3.11.3 France Market Size and Forecast, by Technology
      • 17.3.11.4 France Market Size and Forecast, by Application
      • 17.3.11.5 France Market Size and Forecast, by End User
      • 17.3.11.6 France Market Size and Forecast, by Component
      • 17.3.11.7 France Market Size and Forecast, by Device
      • 17.3.11.8 France Market Size and Forecast, by Deployment
      • 17.3.11.9 France Market Size and Forecast, by Stage
      • 17.3.11.10 France Market Size and Forecast, by Solutions
      • 17.3.11.11 Local Competition Analysis
      • 17.3.11.12 Local Market Analysis
    • 17.3.1 Spain
      • 17.3.12.1 Spain Market Size and Forecast, by Type
      • 17.3.12.2 Spain Market Size and Forecast, by Product
      • 17.3.12.3 Spain Market Size and Forecast, by Technology
      • 17.3.12.4 Spain Market Size and Forecast, by Application
      • 17.3.12.5 Spain Market Size and Forecast, by End User
      • 17.3.12.6 Spain Market Size and Forecast, by Component
      • 17.3.12.7 Spain Market Size and Forecast, by Device
      • 17.3.12.8 Spain Market Size and Forecast, by Deployment
      • 17.3.12.9 Spain Market Size and Forecast, by Stage
      • 17.3.12.10 Spain Market Size and Forecast, by Solutions
      • 17.3.12.11 Local Competition Analysis
      • 17.3.12.12 Local Market Analysis
    • 17.3.1 Italy
      • 17.3.13.1 Italy Market Size and Forecast, by Type
      • 17.3.13.2 Italy Market Size and Forecast, by Product
      • 17.3.13.3 Italy Market Size and Forecast, by Technology
      • 17.3.13.4 Italy Market Size and Forecast, by Application
      • 17.3.13.5 Italy Market Size and Forecast, by End User
      • 17.3.13.6 Italy Market Size and Forecast, by Component
      • 17.3.13.7 Italy Market Size and Forecast, by Device
      • 17.3.13.8 Italy Market Size and Forecast, by Deployment
      • 17.3.13.9 Italy Market Size and Forecast, by Stage
      • 17.3.13.10 Italy Market Size and Forecast, by Solutions
      • 17.3.13.11 Local Competition Analysis
      • 17.3.13.12 Local Market Analysis
    • 17.3.1 Netherlands
      • 17.3.14.1 Netherlands Market Size and Forecast, by Type
      • 17.3.14.2 Netherlands Market Size and Forecast, by Product
      • 17.3.14.3 Netherlands Market Size and Forecast, by Technology
      • 17.3.14.4 Netherlands Market Size and Forecast, by Application
      • 17.3.14.5 Netherlands Market Size and Forecast, by End User
      • 17.3.14.6 Netherlands Market Size and Forecast, by Component
      • 17.3.14.7 Netherlands Market Size and Forecast, by Device
      • 17.3.14.8 Netherlands Market Size and Forecast, by Deployment
      • 17.3.14.9 Netherlands Market Size and Forecast, by Stage
      • 17.3.14.10 Netherlands Market Size and Forecast, by Solutions
      • 17.3.14.11 Local Competition Analysis
      • 17.3.14.12 Local Market Analysis
    • 17.3.1 Sweden
      • 17.3.15.1 Sweden Market Size and Forecast, by Type
      • 17.3.15.2 Sweden Market Size and Forecast, by Product
      • 17.3.15.3 Sweden Market Size and Forecast, by Technology
      • 17.3.15.4 Sweden Market Size and Forecast, by Application
      • 17.3.15.5 Sweden Market Size and Forecast, by End User
      • 17.3.15.6 Sweden Market Size and Forecast, by Component
      • 17.3.15.7 Sweden Market Size and Forecast, by Device
      • 17.3.15.8 Sweden Market Size and Forecast, by Deployment
      • 17.3.15.9 Sweden Market Size and Forecast, by Stage
      • 17.3.15.10 Sweden Market Size and Forecast, by Solutions
      • 17.3.15.11 Local Competition Analysis
      • 17.3.15.12 Local Market Analysis
    • 17.3.1 Switzerland
      • 17.3.16.1 Switzerland Market Size and Forecast, by Type
      • 17.3.16.2 Switzerland Market Size and Forecast, by Product
      • 17.3.16.3 Switzerland Market Size and Forecast, by Technology
      • 17.3.16.4 Switzerland Market Size and Forecast, by Application
      • 17.3.16.5 Switzerland Market Size and Forecast, by End User
      • 17.3.16.6 Switzerland Market Size and Forecast, by Component
      • 17.3.16.7 Switzerland Market Size and Forecast, by Device
      • 17.3.16.8 Switzerland Market Size and Forecast, by Deployment
      • 17.3.16.9 Switzerland Market Size and Forecast, by Stage
      • 17.3.16.10 Switzerland Market Size and Forecast, by Solutions
      • 17.3.16.11 Local Competition Analysis
      • 17.3.16.12 Local Market Analysis
    • 17.3.1 Denmark
      • 17.3.17.1 Denmark Market Size and Forecast, by Type
      • 17.3.17.2 Denmark Market Size and Forecast, by Product
      • 17.3.17.3 Denmark Market Size and Forecast, by Technology
      • 17.3.17.4 Denmark Market Size and Forecast, by Application
      • 17.3.17.5 Denmark Market Size and Forecast, by End User
      • 17.3.17.6 Denmark Market Size and Forecast, by Component
      • 17.3.17.7 Denmark Market Size and Forecast, by Device
      • 17.3.17.8 Denmark Market Size and Forecast, by Deployment
      • 17.3.17.9 Denmark Market Size and Forecast, by Stage
      • 17.3.17.10 Denmark Market Size and Forecast, by Solutions
      • 17.3.17.11 Local Competition Analysis
      • 17.3.17.12 Local Market Analysis
    • 17.3.1 Finland
      • 17.3.18.1 Finland Market Size and Forecast, by Type
      • 17.3.18.2 Finland Market Size and Forecast, by Product
      • 17.3.18.3 Finland Market Size and Forecast, by Technology
      • 17.3.18.4 Finland Market Size and Forecast, by Application
      • 17.3.18.5 Finland Market Size and Forecast, by End User
      • 17.3.18.6 Finland Market Size and Forecast, by Component
      • 17.3.18.7 Finland Market Size and Forecast, by Device
      • 17.3.18.8 Finland Market Size and Forecast, by Deployment
      • 17.3.18.9 Finland Market Size and Forecast, by Stage
      • 17.3.18.10 Finland Market Size and Forecast, by Solutions
      • 17.3.18.11 Local Competition Analysis
      • 17.3.18.12 Local Market Analysis
    • 17.3.1 Russia
      • 17.3.19.1 Russia Market Size and Forecast, by Type
      • 17.3.19.2 Russia Market Size and Forecast, by Product
      • 17.3.19.3 Russia Market Size and Forecast, by Technology
      • 17.3.19.4 Russia Market Size and Forecast, by Application
      • 17.3.19.5 Russia Market Size and Forecast, by End User
      • 17.3.19.6 Russia Market Size and Forecast, by Component
      • 17.3.19.7 Russia Market Size and Forecast, by Device
      • 17.3.19.8 Russia Market Size and Forecast, by Deployment
      • 17.3.19.9 Russia Market Size and Forecast, by Stage
      • 17.3.19.10 Russia Market Size and Forecast, by Solutions
      • 17.3.19.11 Local Competition Analysis
      • 17.3.19.12 Local Market Analysis
    • 17.3.1 Rest of Europe
      • 17.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 17.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 17.3.20.3 Rest of Europe Market Size and Forecast, by Technology
      • 17.3.20.4 Rest of Europe Market Size and Forecast, by Application
      • 17.3.20.5 Rest of Europe Market Size and Forecast, by End User
      • 17.3.20.6 Rest of Europe Market Size and Forecast, by Component
      • 17.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 17.3.20.8 Rest of Europe Market Size and Forecast, by Deployment
      • 17.3.20.9 Rest of Europe Market Size and Forecast, by Stage
      • 17.3.20.10 Rest of Europe Market Size and Forecast, by Solutions
      • 17.3.20.11 Local Competition Analysis
      • 17.3.20.12 Local Market Analysis
  • 17.1 Asia-Pacific
    • 17.4.1 Key Market Trends and Opportunities
    • 17.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 17.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 17.4.4 Asia-Pacific Market Size and Forecast, by Technology
    • 17.4.5 Asia-Pacific Market Size and Forecast, by Application
    • 17.4.6 Asia-Pacific Market Size and Forecast, by End User
    • 17.4.7 Asia-Pacific Market Size and Forecast, by Component
    • 17.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 17.4.9 Asia-Pacific Market Size and Forecast, by Deployment
    • 17.4.10 Asia-Pacific Market Size and Forecast, by Stage
    • 17.4.11 Asia-Pacific Market Size and Forecast, by Solutions
    • 17.4.12 Asia-Pacific Market Size and Forecast, by Country
    • 17.4.13 China
      • 17.4.9.1 China Market Size and Forecast, by Type
      • 17.4.9.2 China Market Size and Forecast, by Product
      • 17.4.9.3 China Market Size and Forecast, by Technology
      • 17.4.9.4 China Market Size and Forecast, by Application
      • 17.4.9.5 China Market Size and Forecast, by End User
      • 17.4.9.6 China Market Size and Forecast, by Component
      • 17.4.9.7 China Market Size and Forecast, by Device
      • 17.4.9.8 China Market Size and Forecast, by Deployment
      • 17.4.9.9 China Market Size and Forecast, by Stage
      • 17.4.9.10 China Market Size and Forecast, by Solutions
      • 17.4.9.11 Local Competition Analysis
      • 17.4.9.12 Local Market Analysis
    • 17.4.1 India
      • 17.4.10.1 India Market Size and Forecast, by Type
      • 17.4.10.2 India Market Size and Forecast, by Product
      • 17.4.10.3 India Market Size and Forecast, by Technology
      • 17.4.10.4 India Market Size and Forecast, by Application
      • 17.4.10.5 India Market Size and Forecast, by End User
      • 17.4.10.6 India Market Size and Forecast, by Component
      • 17.4.10.7 India Market Size and Forecast, by Device
      • 17.4.10.8 India Market Size and Forecast, by Deployment
      • 17.4.10.9 India Market Size and Forecast, by Stage
      • 17.4.10.10 India Market Size and Forecast, by Solutions
      • 17.4.10.11 Local Competition Analysis
      • 17.4.10.12 Local Market Analysis
    • 17.4.1 Japan
      • 17.4.11.1 Japan Market Size and Forecast, by Type
      • 17.4.11.2 Japan Market Size and Forecast, by Product
      • 17.4.11.3 Japan Market Size and Forecast, by Technology
      • 17.4.11.4 Japan Market Size and Forecast, by Application
      • 17.4.11.5 Japan Market Size and Forecast, by End User
      • 17.4.11.6 Japan Market Size and Forecast, by Component
      • 17.4.11.7 Japan Market Size and Forecast, by Device
      • 17.4.11.8 Japan Market Size and Forecast, by Deployment
      • 17.4.11.9 Japan Market Size and Forecast, by Stage
      • 17.4.11.10 Japan Market Size and Forecast, by Solutions
      • 17.4.11.11 Local Competition Analysis
      • 17.4.11.12 Local Market Analysis
    • 17.4.1 South Korea
      • 17.4.12.1 South Korea Market Size and Forecast, by Type
      • 17.4.12.2 South Korea Market Size and Forecast, by Product
      • 17.4.12.3 South Korea Market Size and Forecast, by Technology
      • 17.4.12.4 South Korea Market Size and Forecast, by Application
      • 17.4.12.5 South Korea Market Size and Forecast, by End User
      • 17.4.12.6 South Korea Market Size and Forecast, by Component
      • 17.4.12.7 South Korea Market Size and Forecast, by Device
      • 17.4.12.8 South Korea Market Size and Forecast, by Deployment
      • 17.4.12.9 South Korea Market Size and Forecast, by Stage
      • 17.4.12.10 South Korea Market Size and Forecast, by Solutions
      • 17.4.12.11 Local Competition Analysis
      • 17.4.12.12 Local Market Analysis
    • 17.4.1 Australia
      • 17.4.13.1 Australia Market Size and Forecast, by Type
      • 17.4.13.2 Australia Market Size and Forecast, by Product
      • 17.4.13.3 Australia Market Size and Forecast, by Technology
      • 17.4.13.4 Australia Market Size and Forecast, by Application
      • 17.4.13.5 Australia Market Size and Forecast, by End User
      • 17.4.13.6 Australia Market Size and Forecast, by Component
      • 17.4.13.7 Australia Market Size and Forecast, by Device
      • 17.4.13.8 Australia Market Size and Forecast, by Deployment
      • 17.4.13.9 Australia Market Size and Forecast, by Stage
      • 17.4.13.10 Australia Market Size and Forecast, by Solutions
      • 17.4.13.11 Local Competition Analysis
      • 17.4.13.12 Local Market Analysis
    • 17.4.1 Singapore
      • 17.4.14.1 Singapore Market Size and Forecast, by Type
      • 17.4.14.2 Singapore Market Size and Forecast, by Product
      • 17.4.14.3 Singapore Market Size and Forecast, by Technology
      • 17.4.14.4 Singapore Market Size and Forecast, by Application
      • 17.4.14.5 Singapore Market Size and Forecast, by End User
      • 17.4.14.6 Singapore Market Size and Forecast, by Component
      • 17.4.14.7 Singapore Market Size and Forecast, by Device
      • 17.4.14.8 Singapore Market Size and Forecast, by Deployment
      • 17.4.14.9 Singapore Market Size and Forecast, by Stage
      • 17.4.14.10 Singapore Market Size and Forecast, by Solutions
      • 17.4.14.11 Local Competition Analysis
      • 17.4.14.12 Local Market Analysis
    • 17.4.1 Indonesia
      • 17.4.15.1 Indonesia Market Size and Forecast, by Type
      • 17.4.15.2 Indonesia Market Size and Forecast, by Product
      • 17.4.15.3 Indonesia Market Size and Forecast, by Technology
      • 17.4.15.4 Indonesia Market Size and Forecast, by Application
      • 17.4.15.5 Indonesia Market Size and Forecast, by End User
      • 17.4.15.6 Indonesia Market Size and Forecast, by Component
      • 17.4.15.7 Indonesia Market Size and Forecast, by Device
      • 17.4.15.8 Indonesia Market Size and Forecast, by Deployment
      • 17.4.15.9 Indonesia Market Size and Forecast, by Stage
      • 17.4.15.10 Indonesia Market Size and Forecast, by Solutions
      • 17.4.15.11 Local Competition Analysis
      • 17.4.15.12 Local Market Analysis
    • 17.4.1 Taiwan
      • 17.4.16.1 Taiwan Market Size and Forecast, by Type
      • 17.4.16.2 Taiwan Market Size and Forecast, by Product
      • 17.4.16.3 Taiwan Market Size and Forecast, by Technology
      • 17.4.16.4 Taiwan Market Size and Forecast, by Application
      • 17.4.16.5 Taiwan Market Size and Forecast, by End User
      • 17.4.16.6 Taiwan Market Size and Forecast, by Component
      • 17.4.16.7 Taiwan Market Size and Forecast, by Device
      • 17.4.16.8 Taiwan Market Size and Forecast, by Deployment
      • 17.4.16.9 Taiwan Market Size and Forecast, by Stage
      • 17.4.16.10 Taiwan Market Size and Forecast, by Solutions
      • 17.4.16.11 Local Competition Analysis
      • 17.4.16.12 Local Market Analysis
    • 17.4.1 Malaysia
      • 17.4.17.1 Malaysia Market Size and Forecast, by Type
      • 17.4.17.2 Malaysia Market Size and Forecast, by Product
      • 17.4.17.3 Malaysia Market Size and Forecast, by Technology
      • 17.4.17.4 Malaysia Market Size and Forecast, by Application
      • 17.4.17.5 Malaysia Market Size and Forecast, by End User
      • 17.4.17.6 Malaysia Market Size and Forecast, by Component
      • 17.4.17.7 Malaysia Market Size and Forecast, by Device
      • 17.4.17.8 Malaysia Market Size and Forecast, by Deployment
      • 17.4.17.9 Malaysia Market Size and Forecast, by Stage
      • 17.4.17.10 Malaysia Market Size and Forecast, by Solutions
      • 17.4.17.11 Local Competition Analysis
      • 17.4.17.12 Local Market Analysis
    • 17.4.1 Rest of Asia-Pacific
      • 17.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 17.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 17.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 17.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 17.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 17.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 17.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 17.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Deployment
      • 17.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Stage
      • 17.4.18.10 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 17.4.18.11 Local Competition Analysis
      • 17.4.18.12 Local Market Analysis
  • 17.1 Latin America
    • 17.5.1 Key Market Trends and Opportunities
    • 17.5.2 Latin America Market Size and Forecast, by Type
    • 17.5.3 Latin America Market Size and Forecast, by Product
    • 17.5.4 Latin America Market Size and Forecast, by Technology
    • 17.5.5 Latin America Market Size and Forecast, by Application
    • 17.5.6 Latin America Market Size and Forecast, by End User
    • 17.5.7 Latin America Market Size and Forecast, by Component
    • 17.5.8 Latin America Market Size and Forecast, by Device
    • 17.5.9 Latin America Market Size and Forecast, by Deployment
    • 17.5.10 Latin America Market Size and Forecast, by Stage
    • 17.5.11 Latin America Market Size and Forecast, by Solutions
    • 17.5.12 Latin America Market Size and Forecast, by Country
    • 17.5.13 Brazil
      • 17.5.9.1 Brazil Market Size and Forecast, by Type
      • 17.5.9.2 Brazil Market Size and Forecast, by Product
      • 17.5.9.3 Brazil Market Size and Forecast, by Technology
      • 17.5.9.4 Brazil Market Size and Forecast, by Application
      • 17.5.9.5 Brazil Market Size and Forecast, by End User
      • 17.5.9.6 Brazil Market Size and Forecast, by Component
      • 17.5.9.7 Brazil Market Size and Forecast, by Device
      • 17.5.9.8 Brazil Market Size and Forecast, by Deployment
      • 17.5.9.9 Brazil Market Size and Forecast, by Stage
      • 17.5.9.10 Brazil Market Size and Forecast, by Solutions
      • 17.5.9.11 Local Competition Analysis
      • 17.5.9.12 Local Market Analysis
    • 17.5.1 Mexico
      • 17.5.10.1 Mexico Market Size and Forecast, by Type
      • 17.5.10.2 Mexico Market Size and Forecast, by Product
      • 17.5.10.3 Mexico Market Size and Forecast, by Technology
      • 17.5.10.4 Mexico Market Size and Forecast, by Application
      • 17.5.10.5 Mexico Market Size and Forecast, by End User
      • 17.5.10.6 Mexico Market Size and Forecast, by Component
      • 17.5.10.7 Mexico Market Size and Forecast, by Device
      • 17.5.10.8 Mexico Market Size and Forecast, by Deployment
      • 17.5.10.9 Mexico Market Size and Forecast, by Stage
      • 17.5.10.10 Mexico Market Size and Forecast, by Solutions
      • 17.5.10.11 Local Competition Analysis
      • 17.5.10.12 Local Market Analysis
    • 17.5.1 Argentina
      • 17.5.11.1 Argentina Market Size and Forecast, by Type
      • 17.5.11.2 Argentina Market Size and Forecast, by Product
      • 17.5.11.3 Argentina Market Size and Forecast, by Technology
      • 17.5.11.4 Argentina Market Size and Forecast, by Application
      • 17.5.11.5 Argentina Market Size and Forecast, by End User
      • 17.5.11.6 Argentina Market Size and Forecast, by Component
      • 17.5.11.7 Argentina Market Size and Forecast, by Device
      • 17.5.11.8 Argentina Market Size and Forecast, by Deployment
      • 17.5.11.9 Argentina Market Size and Forecast, by Stage
      • 17.5.11.10 Argentina Market Size and Forecast, by Solutions
      • 17.5.11.11 Local Competition Analysis
      • 17.5.11.12 Local Market Analysis
    • 17.5.1 Rest of Latin America
      • 17.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 17.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 17.5.12.3 Rest of Latin America Market Size and Forecast, by Technology
      • 17.5.12.4 Rest of Latin America Market Size and Forecast, by Application
      • 17.5.12.5 Rest of Latin America Market Size and Forecast, by End User
      • 17.5.12.6 Rest of Latin America Market Size and Forecast, by Component
      • 17.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 17.5.12.8 Rest of Latin America Market Size and Forecast, by Deployment
      • 17.5.12.9 Rest of Latin America Market Size and Forecast, by Stage
      • 17.5.12.10 Rest of Latin America Market Size and Forecast, by Solutions
      • 17.5.12.11 Local Competition Analysis
      • 17.5.12.12 Local Market Analysis
  • 17.1 Middle East and Africa
    • 17.6.1 Key Market Trends and Opportunities
    • 17.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 17.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 17.6.4 Middle East and Africa Market Size and Forecast, by Technology
    • 17.6.5 Middle East and Africa Market Size and Forecast, by Application
    • 17.6.6 Middle East and Africa Market Size and Forecast, by End User
    • 17.6.7 Middle East and Africa Market Size and Forecast, by Component
    • 17.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 17.6.9 Middle East and Africa Market Size and Forecast, by Deployment
    • 17.6.10 Middle East and Africa Market Size and Forecast, by Stage
    • 17.6.11 Middle East and Africa Market Size and Forecast, by Solutions
    • 17.6.12 Middle East and Africa Market Size and Forecast, by Country
    • 17.6.13 Saudi Arabia
      • 17.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 17.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 17.6.9.3 Saudi Arabia Market Size and Forecast, by Technology
      • 17.6.9.4 Saudi Arabia Market Size and Forecast, by Application
      • 17.6.9.5 Saudi Arabia Market Size and Forecast, by End User
      • 17.6.9.6 Saudi Arabia Market Size and Forecast, by Component
      • 17.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 17.6.9.8 Saudi Arabia Market Size and Forecast, by Deployment
      • 17.6.9.9 Saudi Arabia Market Size and Forecast, by Stage
      • 17.6.9.10 Saudi Arabia Market Size and Forecast, by Solutions
      • 17.6.9.11 Local Competition Analysis
      • 17.6.9.12 Local Market Analysis
    • 17.6.1 UAE
      • 17.6.10.1 UAE Market Size and Forecast, by Type
      • 17.6.10.2 UAE Market Size and Forecast, by Product
      • 17.6.10.3 UAE Market Size and Forecast, by Technology
      • 17.6.10.4 UAE Market Size and Forecast, by Application
      • 17.6.10.5 UAE Market Size and Forecast, by End User
      • 17.6.10.6 UAE Market Size and Forecast, by Component
      • 17.6.10.7 UAE Market Size and Forecast, by Device
      • 17.6.10.8 UAE Market Size and Forecast, by Deployment
      • 17.6.10.9 UAE Market Size and Forecast, by Stage
      • 17.6.10.10 UAE Market Size and Forecast, by Solutions
      • 17.6.10.11 Local Competition Analysis
      • 17.6.10.12 Local Market Analysis
    • 17.6.1 South Africa
      • 17.6.11.1 South Africa Market Size and Forecast, by Type
      • 17.6.11.2 South Africa Market Size and Forecast, by Product
      • 17.6.11.3 South Africa Market Size and Forecast, by Technology
      • 17.6.11.4 South Africa Market Size and Forecast, by Application
      • 17.6.11.5 South Africa Market Size and Forecast, by End User
      • 17.6.11.6 South Africa Market Size and Forecast, by Component
      • 17.6.11.7 South Africa Market Size and Forecast, by Device
      • 17.6.11.8 South Africa Market Size and Forecast, by Deployment
      • 17.6.11.9 South Africa Market Size and Forecast, by Stage
      • 17.6.11.10 South Africa Market Size and Forecast, by Solutions
      • 17.6.11.11 Local Competition Analysis
      • 17.6.11.12 Local Market Analysis
    • 17.6.1 Rest of MEA
      • 17.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 17.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 17.6.12.3 Rest of MEA Market Size and Forecast, by Technology
      • 17.6.12.4 Rest of MEA Market Size and Forecast, by Application
      • 17.6.12.5 Rest of MEA Market Size and Forecast, by End User
      • 17.6.12.6 Rest of MEA Market Size and Forecast, by Component
      • 17.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 17.6.12.8 Rest of MEA Market Size and Forecast, by Deployment
      • 17.6.12.9 Rest of MEA Market Size and Forecast, by Stage
      • 17.6.12.10 Rest of MEA Market Size and Forecast, by Solutions
      • 17.6.12.11 Local Competition Analysis
      • 17.6.12.12 Local Market Analysis

18: Competitive Landscape

  • 18.1 Overview
  • 18.2 Market Share Analysis
  • 18.3 Key Player Positioning
  • 18.4 Competitive Leadership Mapping
    • 18.4.1 Star Players
    • 18.4.2 Innovators
    • 18.4.3 Emerging Players
  • 18.5 Vendor Benchmarking
  • 18.6 Developmental Strategy Benchmarking
    • 18.6.1 New Product Developments
    • 18.6.2 Product Launches
    • 18.6.3 Business Expansions
    • 18.6.4 Partnerships, Joint Ventures, and Collaborations
    • 18.6.5 Mergers and Acquisitions

19: Company Profiles

  • 19.1 Crane Composites
    • 19.1.1 Company Overview
    • 19.1.2 Company Snapshot
    • 19.1.3 Business Segments
    • 19.1.4 Business Performance
    • 19.1.5 Product Offerings
    • 19.1.6 Key Developmental Strategies
    • 19.1.7 SWOT Analysis
  • 19.2 Panolam Industries
    • 19.2.1 Company Overview
    • 19.2.2 Company Snapshot
    • 19.2.3 Business Segments
    • 19.2.4 Business Performance
    • 19.2.5 Product Offerings
    • 19.2.6 Key Developmental Strategies
    • 19.2.7 SWOT Analysis
  • 19.3 Lamilux Heinrich Strunz Group
    • 19.3.1 Company Overview
    • 19.3.2 Company Snapshot
    • 19.3.3 Business Segments
    • 19.3.4 Business Performance
    • 19.3.5 Product Offerings
    • 19.3.6 Key Developmental Strategies
    • 19.3.7 SWOT Analysis
  • 19.4 Fiber-Tech Industries
    • 19.4.1 Company Overview
    • 19.4.2 Company Snapshot
    • 19.4.3 Business Segments
    • 19.4.4 Business Performance
    • 19.4.5 Product Offerings
    • 19.4.6 Key Developmental Strategies
    • 19.4.7 SWOT Analysis
  • 19.5 Enduro Composites
    • 19.5.1 Company Overview
    • 19.5.2 Company Snapshot
    • 19.5.3 Business Segments
    • 19.5.4 Business Performance
    • 19.5.5 Product Offerings
    • 19.5.6 Key Developmental Strategies
    • 19.5.7 SWOT Analysis
  • 19.6 Glasteel
    • 19.6.1 Company Overview
    • 19.6.2 Company Snapshot
    • 19.6.3 Business Segments
    • 19.6.4 Business Performance
    • 19.6.5 Product Offerings
    • 19.6.6 Key Developmental Strategies
    • 19.6.7 SWOT Analysis
  • 19.7 Nudo Products
    • 19.7.1 Company Overview
    • 19.7.2 Company Snapshot
    • 19.7.3 Business Segments
    • 19.7.4 Business Performance
    • 19.7.5 Product Offerings
    • 19.7.6 Key Developmental Strategies
    • 19.7.7 SWOT Analysis
  • 19.8 Polser Fiberglass Reinforced Plastics
    • 19.8.1 Company Overview
    • 19.8.2 Company Snapshot
    • 19.8.3 Business Segments
    • 19.8.4 Business Performance
    • 19.8.5 Product Offerings
    • 19.8.6 Key Developmental Strategies
    • 19.8.7 SWOT Analysis
  • 19.9 Strongwell Corporation
    • 19.9.1 Company Overview
    • 19.9.2 Company Snapshot
    • 19.9.3 Business Segments
    • 19.9.4 Business Performance
    • 19.9.5 Product Offerings
    • 19.9.6 Key Developmental Strategies
    • 19.9.7 SWOT Analysis
  • 19.10 Brianza Plastica
    • 19.10.1 Company Overview
    • 19.10.2 Company Snapshot
    • 19.10.3 Business Segments
    • 19.10.4 Business Performance
    • 19.10.5 Product Offerings
    • 19.10.6 Key Developmental Strategies
    • 19.10.7 SWOT Analysis
  • 19.11 Optiplan GmbH
    • 19.11.1 Company Overview
    • 19.11.2 Company Snapshot
    • 19.11.3 Business Segments
    • 19.11.4 Business Performance
    • 19.11.5 Product Offerings
    • 19.11.6 Key Developmental Strategies
    • 19.11.7 SWOT Analysis
  • 19.12 Dongguan Hengsu Green Building Material
    • 19.12.1 Company Overview
    • 19.12.2 Company Snapshot
    • 19.12.3 Business Segments
    • 19.12.4 Business Performance
    • 19.12.5 Product Offerings
    • 19.12.6 Key Developmental Strategies
    • 19.12.7 SWOT Analysis
  • 19.13 Fibrosan
    • 19.13.1 Company Overview
    • 19.13.2 Company Snapshot
    • 19.13.3 Business Segments
    • 19.13.4 Business Performance
    • 19.13.5 Product Offerings
    • 19.13.6 Key Developmental Strategies
    • 19.13.7 SWOT Analysis
  • 19.14 U.S. Liner Company
    • 19.14.1 Company Overview
    • 19.14.2 Company Snapshot
    • 19.14.3 Business Segments
    • 19.14.4 Business Performance
    • 19.14.5 Product Offerings
    • 19.14.6 Key Developmental Strategies
    • 19.14.7 SWOT Analysis
  • 19.15 Resolite FRP Composites
    • 19.15.1 Company Overview
    • 19.15.2 Company Snapshot
    • 19.15.3 Business Segments
    • 19.15.4 Business Performance
    • 19.15.5 Product Offerings
    • 19.15.6 Key Developmental Strategies
    • 19.15.7 SWOT Analysis
  • 19.16 Stabilit America
    • 19.16.1 Company Overview
    • 19.16.2 Company Snapshot
    • 19.16.3 Business Segments
    • 19.16.4 Business Performance
    • 19.16.5 Product Offerings
    • 19.16.6 Key Developmental Strategies
    • 19.16.7 SWOT Analysis
  • 19.17 Exel Composites
    • 19.17.1 Company Overview
    • 19.17.2 Company Snapshot
    • 19.17.3 Business Segments
    • 19.17.4 Business Performance
    • 19.17.5 Product Offerings
    • 19.17.6 Key Developmental Strategies
    • 19.17.7 SWOT Analysis
  • 19.18 Fiberglass Coatings
    • 19.18.1 Company Overview
    • 19.18.2 Company Snapshot
    • 19.18.3 Business Segments
    • 19.18.4 Business Performance
    • 19.18.5 Product Offerings
    • 19.18.6 Key Developmental Strategies
    • 19.18.7 SWOT Analysis
  • 19.19 Fiber-Tech Industries
    • 19.19.1 Company Overview
    • 19.19.2 Company Snapshot
    • 19.19.3 Business Segments
    • 19.19.4 Business Performance
    • 19.19.5 Product Offerings
    • 19.19.6 Key Developmental Strategies
    • 19.19.7 SWOT Analysis
  • 19.20 Creative Pultrusions
    • 19.20.1 Company Overview
    • 19.20.2 Company Snapshot
    • 19.20.3 Business Segments
    • 19.20.4 Business Performance
    • 19.20.5 Product Offerings
    • 19.20.6 Key Developmental Strategies
    • 19.20.7 SWOT Analysis